Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
P. falciparum growth and inhibition assays from US Patent US11903936: "Anti-malarial agents"
Assay data:12 Active, 12 Activity ≤ 1 µM, 12 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
DHODH Kinetic Analysis from US Patent US11903936: "Anti-malarial agents"
Assay data:13 Active, 13 Activity ≤ 1 µM, 13 Tested
Inhibition of Beta-hematin in Plasmodium berghei
Assay data:1 Tested
SummaryPubMed Citation
Antimalarial activity against chloroquine-sensitive Plasmodium falciparum NF54 measured after 72 hrs by giemsa staining based analysis
Assay data:4 Active, 4 Tested
SummaryCompounds, ActivePubMed Citation
Antimalarial activity against plasmodium falciparum 3D7 assessed as bacterial growth inhibition
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Inhibition of plasmodium falciparum fabZ
Antimalarial activity against drug sensitive Plasmodium falciparum KI assessed as inhibition of parasite growth
Assay data:1 Active, 1 Tested
Antimalarial activity against drug sensitive Plasmodium falciparum NF54 assessed as inhibition of parasite growth
Antimalarial activity against chloroquine sensitive Plasmodium falciparum FCR-3 infected in mouse FM3A cells ssessed as reduction in parasite growth
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
Antiplasmodial activity against Plasmodium falciparum D6 assessed as reduction in plasmodial growth after 48 hrs by fluorescence based analysis
Assay data:3 Tested
Antiplasmodial activity against Plasmodium falciparum W2 assessed as reduction in plasmodial growth after 48 hrs by fluorescence based analysis
Antiplasmodial activity against Plasmodium falciparum assessed as reduction in parasite growth
Antiplasmodial activity against multidrug resistant Plasmodium falciparum Dd2 assessed as reduction in parasite growth
Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 expressing extra copies of GFP-tagged TPK plasmid infected in human erythrocyte assessed as inhibition of parasite proliferation in thiamine free medium by SYBR-Safe assay
Assay data:1 Active, 2 Tested
Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 transfected with empty plasmid infected in human erythrocyte assessed as inhibition of parasite proliferation in thiamine free medium by SYBR-Safe assay
Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte assessed as inhibition of parasite proliferation in presence of 297uM thiamine by SYBR-Safe assay
Assay data:2 Active, 9 Tested
Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte assessed as inhibition of parasite proliferation in presence of 2.97uM thiamine by SYBR-Safe assay
Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum 3D7 infected in human erythrocyte assessed as inhibition of parasite proliferation in thiamine free medium by SYBR-Safe assay
Assay data:2 Active, 1 Activity ≤ 1 µM, 9 Tested
Antiplasmodial activity against Plasmodium falciparum 3D7 infected in human erythrocyte assessed as intraerythrocytic growth inhibition in presence thiamine-rich medium by [3H]-hypoxanthine incorporation assay
Antiplasmodial activity against Plasmodium falciparum 3D7 infected in human erythrocyte assessed as intraerythrocytic growth inhibition in thiamine-free medium by [3H]-hypoxanthine incorporation assay
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on